Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Progenitor Cell Mobilization

Effect of prior chemotherapy on hematopoietic stem cell mobilization

Bone Marrow Transplantation volume 33, pages 901–905 (2004)Cite this article

Summary:

A number of studies have suggested that prior chemotherapy correlates negatively with the efficiency of hematopoietic stem cell mobilization. However, little data exist with regard to the relative effects of the specific chemotherapeutic drug classes. We retrospectively reviewed the records of 201 consecutive patients with nonmyeloid malignancies undergoing CD34+ cell mobilization with chemotherapy+granulocyte colony-stimulating factor (G-CSF). The number of prior chemotherapy courses correlated negatively with the peripheral CD34+ cell concentration (pCD34) on the first day of collection (P<0.001). No significant correlation was found for age, gender, tumor primary, mobilization chemotherapy regimen, disease status, marrow involvement, prior radiation therapy, or dose and timing of G-CSF administration. When the number of courses of individual classes of chemotherapeutic agents was correlated with pCD34, only exposures to platinum compounds (P=0.001) and alkylating agents (P=0.01) were found to be independent negative predictive factors for pCD34. Within classes, DNA crosslinking agents and etoposide appeared possibly more damaging than DNA methylating agents and doxorubicin, respectively. None of the drug classes showed evidence of recovery. We conclude that exposure to chemotherapy, especially platinum compounds and alkylating agents, should be minimized prior to mobilization.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kotasek D, Shepherd KM, Sage RE et al. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11–17.

    CAS  Google Scholar 

  2. Chabannon C, Le Coroller AG, Faucher C et al. Patient condition affects the collection of peripheral blood progenitors after priming with recombinant granulocyte colony-stimulating factor. J Hematother 1995; 4: 171–179.

    Article  CAS  Google Scholar 

  3. Koumakis G, Vassilomanolakis M, Hatzichristou H et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD, CHE) in various malignancies. Bone Marrow Transplant 1996; 18: 1065–1072.

    CAS  Google Scholar 

  4. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787–3794.

    CAS  Google Scholar 

  5. Keung YK, Cobos E, Dunn D et al. Determining factors for the outcome of peripheral blood progenitor cells harvests. J Clin Apheresis 1996; 11: 23–26.

    Article  CAS  Google Scholar 

  6. Humpe A, Riggert J, Vehmeyer K et al. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion 1997; 37: 1050–1057.

    Article  CAS  Google Scholar 

  7. Olivieri A, Offidani M, Ciniero L et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model. Bone Marrow Transplant 1994; 14: 273–278.

    CAS  Google Scholar 

  8. Shepherd KM, Charles P, Sage RE et al. Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies. Clin Lab Haematol 1991; 13: 25–32.

    Article  CAS  Google Scholar 

  9. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13: 2547–2555.

    Article  CAS  Google Scholar 

  10. Imrie K, Stewart K, Crump RM et al. Blood stem cell collection: factors influencing the recovery of granulocyte–macrophage colony forming cells. Cell Transplant 1996; 5: 379–383.

    Article  CAS  Google Scholar 

  11. McQuaker IG, Haynes AP, Stainer C et al. Stem cell mobilization in resistant or relapsed lymphoma. Superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol 1997; 98: 228–233.

    Article  CAS  Google Scholar 

  12. Goldschmidt H, Hegenbart U, Wallmeier M et al. Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 1997; 98: 736–744.

    Article  CAS  Google Scholar 

  13. Morton J, Morton A, Bird R et al. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF. Leukemia Res 1997; 21: 21–27.

    Article  CAS  Google Scholar 

  14. Sutherland R, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213–226.

    Article  CAS  Google Scholar 

  15. Ford CD, Chan K, Reilly WF, Petersen FB . An evaluation of predictive factors for CD34+ cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 2003; 43: 622–625.

    Article  CAS  Google Scholar 

  16. Ford CD, Greenwood J, Strupp A, Lehman CM . Change in CD34+ cell concentration during peripheral blood stem cell collection: effects on collection efficiency and efficacy. Transfusion 2002; 42: 904–911.

    Article  Google Scholar 

  17. Narayanasami U, Kanteti R, Morelli J et al. Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood 2001; 98: 2059–2064.

    Article  CAS  Google Scholar 

  18. Weaver CH, Birch R, Greco L et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br J Haematol 1998; 100: 338–347.

    Article  CAS  Google Scholar 

  19. Demirer T, Ayli M, Ozcan M et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol 2002; 116: 468–474.

    Article  CAS  Google Scholar 

  20. Andre M, Baudoux E, Bron D et al. Phase III randomized study comparing 5 or 10 g per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion 2003; 43: 50–57.

    Article  CAS  Google Scholar 

  21. Drake M, Ranaghan L, Morris TCM et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997; 98: 745–749.

    Article  CAS  Google Scholar 

  22. Clark RE, Brammer CG . Previous treatment predicts the efficiency of blood progenitor cell mobilization: validation of a chemotherapy scoring system. Bone Marrow Transplant 1998; 22: 859–863.

    Article  CAS  Google Scholar 

  23. Neben S, Hemman S, Montgomery M et al. Hematopoietic stem cell deficit of transplanted bone marow previously exposed to cytotoxic agents. Exp Hematol 1993; 21: 156–162.

    CAS  Google Scholar 

  24. Molineux G, Xu C, Hendry J, Testa NG . A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide. Cancer Chemother Pharmacol 1986; 18: 11–16.

    Article  CAS  Google Scholar 

  25. Adler SS, Kuznetshy RD . Effects of chemotherapeutic agents on hemopoietic stromal tissue: I. Effects of cyclophosphamide and bleomycin on hemopoiesis in subcutaneous femur implants. Exp Hematol 1984; 12: 153–161.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Utah Blood and Bone Marrow Transplantation Program, LDS Hospital and University of Utah, Salt Lake City, UT, USA

    C D Ford, W Green, S Warenski & F B Petersen

Authors
  1. C D Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W Green
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Warenski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F B Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C D Ford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ford, C., Green, W., Warenski, S. et al. Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant 33, 901–905 (2004). https://doi.org/10.1038/sj.bmt.1704455

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704455

Keywords

This article is cited by

Search

Advanced search

Quick links